Publications by authors named "Christy Hebner"

Claim this Profile
H
High resistance barrier and prophylactic protection in preclinical models of SARS-CoV-2 with two siRNA combination.
Yesseinia I Anglero-Rodriguez, Florian A Lempp, Megha Subramanian, James McIninch, Mark K Schlegel, Christy M Hebner

Nucleic Acids Res· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Trial to Evaluate the Safety and Efficacy of VIR-2482 in Healthy Adults for Prevention of Influenza A Illness (PENINSULA).
Susanna K Tan, Deborah Cebrik, David Plotnik, Maria L Agostini, Keith Boundy, Christy M Hebner

Clin Infect Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent broadly neutralizing antibody VIR-3434 controls hepatitis B and D virus infection and reduces HBsAg in humanized mice.
Florian A Lempp, Tassilo Volz, Elisabetta Cameroni, Fabio Benigni, Jiayi Zhou, Christy M Hebner

J Hepatol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resistance analysis following sotrovimab treatment in participants with COVID-19 during the phase III COMET-ICE study.
Sambhavi Subramanian, Gretja Schnell, Julia di Iulio, Anil K Gupta, Adrienne E Shapiro, Christy M Hebner

Future Virol· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials.
Ed Gane, Young-Suk Lim, Jae B Kim, Vasant Jadhav, Ling Shen, Christy M Hebner

J Hepatol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Elisabetta Cameroni, John E Bowen, Laura E Rosen, Christian Saliba, Samantha K Zepeda, Christy Hebner

Nature· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift.
Elisabetta Cameroni, Christian Saliba, John E Bowen, Laura E Rosen, Katja Culap, Christy Hebner

bioRxiv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab.
Anil Gupta, Yaneicy Gonzalez-Rojas, Erick Juarez, Manuel Crespo Casal, Jaynier Moya, Christy M Hebner

N Engl J Med· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape.
Tyler N Starr, Nadine Czudnochowski, Zhuoming Liu, Fabrizia Zatta, Young-Jun Park, Christy M Hebner

Nature· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape.
Tyler N Starr, Nadine Czudnochowski, Fabrizia Zatta, Young-Jun Park, Zhuoming Liu, Christy M Hebner

bioRxiv· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potent LpxC Inhibitors with Activity against Multidrug-Resistant Pseudomonas aeruginosa.
Kevin M Krause, Cat M Haglund, Christy Hebner, Alisa W Serio, Grace Lee

Antimicrob Agents Chemother· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In Vitro Characterization of Human Cytomegalovirus-Targeting Therapeutic Monoclonal Antibodies LJP538 and LJP539.
Hetalkumar D Patel, Pavel Nikitin, Thomas Gesner, James J Lin, David T Barkan, Christy M Hebner

Antimicrob Agents Chemother· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody.
Sumana Chandramouli, Claudio Ciferri, Pavel A Nikitin, Stefano Caló, Rachel Gerrein, Christy Hebner

Nat Commun· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infrequent development of resistance in genotype 1-6 hepatitis C virus-infected subjects treated with sofosbuvir in phase 2 and 3 clinical trials.
Evguenia S Svarovskaia, Hadas Dvory-Sobol, Neil Parkin, Christy Hebner, Viktoria Gontcharova

Clin Infect Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial.
Maribel Rodriguez-Torres, Eric Lawitz, Kris V Kowdley, David R Nelson, Edwin Dejesus, Christy M Hebner

J Hepatol· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The HCV non-nucleoside inhibitor Tegobuvir utilizes a novel mechanism of action to inhibit NS5B polymerase function.
Christy M Hebner, Bin Han, Katherine M Brendza, Michelle Nash, Maisoun Sulfab

PLoS One· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymerase.
I-Hung Shih, Inge Vliegen, Betty Peng, Huiling Yang, Christy Hebner

Antimicrob Agents Chemother· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling morphogenesis and oncogenesis in three-dimensional breast epithelial cultures.
Christy Hebner, Valerie M Weaver, Jayanta Debnath

Annu Rev Pathol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomavirus E6 proteins mediate resistance to interferon-induced growth arrest through inhibition of p53 acetylation.
Christy Hebner, Melanie Beglin, Laimonis A Laimins

J Virol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomaviruses target the double-stranded RNA protein kinase pathway.
Christy M Hebner, Regina Wilson, Janet Rader, Miri Bidder, Laimonis A Laimins

J Gen Virol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity.
Christy M Hebner, Laimonis A Laimins

Rev Med Virol· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The spacing between adjacent binding sites in the family of repeats affects the functions of Epstein-Barr nuclear antigen 1 in transcription activation and stable plasmid maintenance.
Christy Hebner, Julie Lasanen, Scott Battle, Ashok Aiyar

Virology· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sonic hedgehog activates mesenchymal Gli1 expression during prostate ductal bud formation.
Marilyn L Lamm, Winnie S Catbagan, Robert J Laciak, Daniel H Barnett, Christy M Hebner

Dev Biol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis